Amgen Inc (AMGN)
319.22
-0.94
(-0.29%)
USD |
NASDAQ |
Nov 01, 16:00
317.56
-1.66
(-0.52%)
After-Hours: 20:00
Amgen Debt to Equity Ratio: 8.024 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 8.024 |
| June 30, 2024 | 10.57 |
| March 31, 2024 | 12.75 |
| December 31, 2023 | 10.37 |
| September 30, 2023 | 7.898 |
| June 30, 2023 | 9.076 |
| March 31, 2023 | 11.52 |
| December 31, 2022 | 10.64 |
| September 30, 2022 | 10.60 |
| June 30, 2022 | 15.10 |
| March 31, 2022 | 40.23 |
| December 31, 2021 | 4.972 |
| September 30, 2021 | 4.573 |
| June 30, 2021 | 3.975 |
| March 31, 2021 | 3.502 |
| December 31, 2020 | 3.506 |
| September 30, 2020 | 3.129 |
| June 30, 2020 | 3.211 |
| March 31, 2020 | 3.358 |
| December 31, 2019 | 3.091 |
| September 30, 2019 | 2.726 |
| June 30, 2019 | 2.836 |
| March 31, 2019 | 3.049 |
| December 31, 2018 | 2.714 |
| September 30, 2018 | 2.399 |
| Date | Value |
|---|---|
| June 30, 2018 | 2.314 |
| March 31, 2018 | 2.275 |
| December 31, 2017 | 1.400 |
| September 30, 2017 | 1.110 |
| June 30, 2017 | 1.105 |
| March 31, 2017 | 1.113 |
| December 31, 2016 | 1.158 |
| September 30, 2016 | 1.148 |
| June 30, 2016 | 1.102 |
| March 31, 2016 | 1.196 |
| December 31, 2015 | 1.119 |
| September 30, 2015 | 1.136 |
| June 30, 2015 | 1.163 |
| March 31, 2015 | 1.145 |
| December 31, 2014 | 1.192 |
| September 30, 2014 | 1.302 |
| June 30, 2014 | 1.367 |
| March 31, 2014 | 1.408 |
| December 31, 2013 | 1.454 |
| September 30, 2013 | 1.251 |
| June 30, 2013 | 1.161 |
| March 31, 2013 | 1.226 |
| December 31, 2012 | 1.392 |
| September 30, 2012 | 1.330 |
| June 30, 2012 | 1.267 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
3.091
Minimum
Dec 2019
40.23
Maximum
Mar 2022
9.004
Average
7.961
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5096 |
| Eli Lilly and Co | 2.185 |
| Merck & Co Inc | 0.8671 |
| Regeneron Pharmaceuticals Inc | 0.0677 |
| Viking Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 90.88B |
| Total Liabilities (Quarterly) | 83.36B |
| Shareholders Equity (Quarterly) | 7.527B |
| Current Ratio | 1.318 |
| Net Debt Paydown Yield | 0.13% |